7/16/2025 - 9:36 AM EST - Satellos Bioscience Inc. : Announced the appointment of Wildon Farwell, M.D., MPH, as chief medical officer. Dr. Farwell joins Satellos from Dyne Therapeutics, where he most recently served as CMO and medical advisor. Satellos Bioscience Inc.
shares T.MSCL are trading unchanged at $0.57.
